Abstract:It has been suggested that protein-protein interaction is important for protein kinase C (PKC) alpha to activate phospholipase D1 (PLD1). To determine the one or more sites on PKCalpha that are involved in binding to PLD1, fragments containing the regulatory domain, catalytic domain, and C1-C3 domain of PKCalpha were constructed and shown to be functional, but they all failed to bind and activate PLD1 in vivo and in vitro. A C-terminal 23-amino acid (aa) deletion mutant of PKCalpha was also found to be inactive. To define the binding/activation site(s) in the C terminus of PKCalpha, 1- to 11-aa deletion mutants were made in this terminus. Deletion of up to 9 aa did not alter the ability of PKCalpha to bind and activate PLDl, whereas a 10-aa deletion was inactive. The residue at position 10 was Phe(663). Mutations of this residue (F663D and F663A) caused loss of binding, activation, and phosphorylation of PLD1, indicating that Phe(663) is essential for these activities. Time course experiments showed that the activation of PLD1 by PMA was much faster than its phosphorylation, and its activity decreased as phosphorylation increased with time. Staurosporine, a PKC inhibitor, completely inhibited PLD1 phosphorylation in response to 4beta-phorbol 12-myristate 13-acetate PMA and blocked the later decrease in PLD activity. The same results were found with the D481E mutant of PKCalpha, which is unable to phosphorylate PLD1. These results indicate that neither the regulatory nor catalytic domains of PKCalpha alone can bind to or activate PLD1 and that a residue in the C terminus of PKCalpha (Phe(663)) is required for these effects. The initial activation of PLD1 by PMA is highly correlated with the binding of PKCalpha. Although PKCalpha can phosphorylate PLD1, this is a relatively slow process and is associated with inactivation of the enzyme.

Regulation of Protein Kinase C Inactivation by Fas-associated Protein with Death Domain

Protein Kinase Cδ in Apoptosis: A Brief Overview

Cellular Dynamics of Fas-Associated Death Domain in the Regulation of Cancer and Inflammation

A critical role of Fas-associated protein with death domain phosphorylation in intracellular reactive oxygen species homeostasis and aging.

CK1δ Kinase Activity is Modulated by Protein Kinase C Α (Pkcα)-Mediated Site-Specific Phosphorylation.

Fadd Phosphorylation Impaired Islet Morphology And Function

Phosphoproteomics Study on the Activated PKCδ-induced Cell Death.

Activation of Protein Kinase C Triggers Its Ubiquitination and Degradation

Phosphorylation by Protein Kinase CK2: a Signaling Switch for the Caspase-Inhibiting Protein ARC.

Mechanisms of regulation of phospholipase D1 by protein kinase Calpha.

Down-Regulation Of Pkhd1 Induces Cell Apoptosis Through Pi3k And Nf-Kappa B Pathways

Protein kinase C inhibits singlet oxygen-induced apoptosis by decreasing caspase-8 activation

Apoptotic potential of Fas-associated death domain on regulation of cell death regulatory protein cFLIP and death receptor mediated apoptosis in HEK 293T cells

Role of Fas-associated Death Domain-Containing Protein (FADD) Phosphorylation in Regulating Glucose Homeostasis: from Proteomic Discovery to Physiological Validation.

Fas-Associated Protein With Death Domain (Fadd) Regulates Autophagy Through Promoting The Expression Of Ras Homolog Enriched In Brain (Rheb) In Human Breast Adenocarcinoma Cells

A point mutation at phenylalanine 663 abolishes protein kinase Cα’s ability to translocate to the perinuclear region and activate phospholipase D1

Calmodulin Mediates Fas-Induced Fadd-Independent Survival Signaling in Pancreatic Cancer Cells Via Activation of Src-Extracellular Signal-Regulated Kinase (Erk)

Fadd is A Key Regulator of Lipid Metabolism

The death receptor Fas mediates a non-apoptotic signaling cascade in apoptosis resistant CD4+ T cells via the MAPK pathway. (P1304)

Regulation of fas ligand expression during activation-induced cell death in T cells by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase.

Regulation of the Viability of Nf1 Deficient Cells by PKC Isoforms